MOH — authorised 29 September 2000
- Marketing authorisation holder: ALPHARMA US PHARMS
- Status: likely_approved
🇮🇱 Propadrine in Israel
MOH authorised Propadrine on 29 September 2000
Marketing authorisation
Propadrine in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in Israel
Frequently asked questions
Is Propadrine approved in Israel?
Yes. MOH authorised it on 29 September 2000.
Who is the marketing authorisation holder for Propadrine in Israel?
ALPHARMA US PHARMS holds the Israeli marketing authorisation.